business

Frida is launching a new line of personal care products for children aged 6 to 11, aiming to fill a gap in the market and expand its presence in retail through partnerships with Walmart and Amazon. This move is significant as it taps into a growing $82 billion market projected to reach $137 billion by 2030.

Eli Lilly's weight-loss drug Foundayo has received its first approval for sale in the U.K., positioning it to compete directly with Novo Nordisk's Wegovy pill. This approval is significant as it introduces a second GLP-1 weight-loss option in Europe, potentially expanding the market for oral weight-loss medications.

President Trump's executive order to reduce the number of recommended childhood vaccines and falsely link them to autism could significantly impact public health policies and vaccine uptake in the U.S.

Nvidia is collaborating with major asset management firms to create a $500 billion financing initiative aimed at bolstering artificial intelligence infrastructure, underscoring the increasing importance of private capital in the AI sector.

Investors are reacting to mixed stock performance amid geopolitical tensions and upcoming economic data, while notable corporate developments include Intel's stock sale and Boeing's strategic divestiture to Archer Aviation.

The U.S. Department of Health and Human Services has proposed new regulations to enhance oversight of food ingredients, requiring manufacturers to notify the FDA when they classify an ingredient as Generally Recognized as Safe (GRAS). This move aims to address growing safety concerns amid rising foodborne illness outbreaks and the prevalence of ultra-processed foods in the American diet.